FibroBiologics releases CYWC628 drug product for diabetic foot ulcer trial
FibroBiologics Inc. (NASDAQ: FBLG) announced it has released the first batch of its CYWC628 drug product for use in a ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
